CT scans are the best alternative to colonoscopy to investigate bowel cancer symptoms

February 14, 2013
CT scans are the best alternative to colonoscopy to investigate bowel cancer symptoms

A scan that offers patients a less invasive test, sometimes called a 'virtual colonoscopy', is more effective than the traditional X-ray test of barium enema and should now be considered alongside the 'gold standard' of colonoscopy for investigating patients with a possible bowel cancer.

But the researchers, funded by the National Institute for Health Research Health Technology Assessment and Cancer Research UK, caution that guidelines are needed before this type of scan, also called (CTC), is used more widely because its ability to detect relatively unimportant findings can result in patients being referred for unnecessary follow-up tests.

In the first of the two trials, published in the today, more than 3,800 patients were given either a CTC or a barium enema. The researchers showed that CTC was more effective than barium enema at finding bowel cancers and .

Professor Steve Halligan, based at UCL and joint-lead researcher, said: "Our trial shows that CTC is more accurate than barium enema. We hope that barium enema will now be phased out in favour of CTC and that NICE will update its guidelines. Although CTC can be performed on standard CT scanners available in practically all NHS hospitals, many do not have radiologists experienced with looking at CTC scans. These radiologists will need training in order to deliver the results we observed in our trials."

In a second trial almost 1,600 patients were given either a CTC or a . Previous studies have shown that these two tests have similar sensitivity for detecting .

Unlike colonoscopy, samples of tissue cannot be taken at CTC and it was not known how many patients needed a follow-up test to either confirm a suspected cancer or to rule out other findings found in the scan. Similarly, it was not known how many patients needed a follow-up test after colonoscopy because the scope could not pass around the bowel.

In patients who had CTC, 30 per cent had a follow-up test compared with only eight per cent who had colonoscopy. Some of the follow-up tests after CTC were necessary because a possible cancer or large polyp had been seen. However, almost a third of follow-up tests were to investigate small polyps that could have been left alone because they are unlikely to develop into cancers.

Professor Wendy Atkin, based at Imperial College London and joint-lead researcher, said: "Understandably hospital doctors are cautious in requesting more tests after CTC. However, CTC detects unimportant findings, so guidelines are needed to help doctors decide who should have a further test.  With these in place, we have shown that CTC offers a viable option for people who are not able to or do not wish to undergo a colonoscopy for whatever reason." 

CTC works by taking hundreds of x-ray "slices" through the body which are then processed by a computer to create a 'virtual' 3D image of the inside of the bowel, similar to what is seen during colonoscopy. CTC is a less uncomfortable test and, unlike colonoscopy, patients do not need to be sedated.

Professor Jane Wardle, based at UCL, who led studies looking into patient experiences of the three tests, said: "We have shown that people prefer CTC to both barium enema and colonoscopy.  This research should mean that patients with bowel cancer symptoms can get the best test for them."

Sara Hiom, Cancer Research UK's director of early diagnosis, said: "Survival rates for bowel cancer have doubled over the last 40 years thanks to better treatments and improved ways of diagnosing the disease. This research will mean that anyone with a suspected bowel cancer has two effective options to further investigate their symptoms."

Explore further: Virtual colonoscopy without laxative equals standard in identifying clinically significant polyps

More information: Halligan, S. Computed tomographic colonography versus double contrast barium enema for diagnosis of colorectal cancer or large polyps in symptomatic patients: a multicentre randomised trial in clinical practice. Lancet (2013).

Atkin, W.S. et al. Computed tomographic colonography versus colonoscopy for investigation of patients with symptoms of colorectal cancer: a multicentre randomised trial in clinical practice. Lancet (2013).

Related Stories

Virtual colonoscopy without laxative equals standard in identifying clinically significant polyps

June 14, 2012
Computed tomographic colonography (CTC), also known as virtual colonoscopy, administered without laxatives is as accurate as conventional colonoscopy in detecting clinically significant, potentially cancerous polyps, according ...

Recommended for you

Cancer-death button gets jammed by gut bacterium

July 27, 2017
Researchers at Michigan Medicine and in China showed that a type of bacterium is associated with the recurrence of colorectal cancer and poor outcomes. They found that Fusobacterium nucleatum in the gut can stop chemotherapy ...

Researchers release first draft of a genome-wide cancer 'dependency map'

July 27, 2017
In one of the largest efforts to build a comprehensive catalog of genetic vulnerabilities in cancer, researchers from the Broad Institute of MIT and Harvard and Dana-Farber Cancer Institute have identified more than 760 genes ...

Long-sought mechanism of metastasis is discovered in pancreatic cancer

July 27, 2017
Cells, just like people, have memories. They retain molecular markers that at the beginning of their existence helped guide their development. Cells that become cancerous may be making use of these early memories to power ...

Blocking the back-door that cancer cells use to escape death by radiotherapy

July 27, 2017
A natural healing mechanism of the body may be reducing the efficiency of radiotherapy in breast cancer patients, according to a new study.

Manmade peptides reduce breast cancer's spread

July 27, 2017
Manmade peptides that directly disrupt the inner workings of a gene known to support cancer's spread significantly reduce metastasis in a mouse model of breast cancer, scientists say.

Glowing tumor technology helps surgeons remove hidden cancer cells

July 27, 2017
Surgeons were able to identify and remove a greater number of cancerous nodules from lung cancer patients when combining intraoperative molecular imaging (IMI) - through the use of a contrast agent that makes tumor cells ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.